Hideo Tohgi

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction

Fumio Gotoh, Hideo Tohgi, Shunsaku Hirai et al. · Journal of Stroke and Cerebrovascular Diseases · 2000 · 345 citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +15

Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging

Satoshi Takahashi, Hisashi Yonezawa, Junko Takahashi et al. · Neuroscience Letters · 2002 · 223 citations

Alzheimer's Disease, Neuroimaging Modality, White Matter +14

Cerebellar infarction. Clinical and neuroimaging analysis in 293 patients. The Tohoku Cerebellar Infarction Study Group.

Hideo Tohgi, Shin Takahashi, K. Chiba et al. · Stroke · 1993 · 223 citations

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.

Hideo Tohgi, Shu Konno, Ken‐ichi Tamura et al. · Stroke · 1992 · 205 citations